DE3851265D1 - Hydrolysierbare Verbindungen, die elektronübertragende Mittel freigeben und ihre analytische Verwendung. - Google Patents

Hydrolysierbare Verbindungen, die elektronübertragende Mittel freigeben und ihre analytische Verwendung.

Info

Publication number
DE3851265D1
DE3851265D1 DE3851265T DE3851265T DE3851265D1 DE 3851265 D1 DE3851265 D1 DE 3851265D1 DE 3851265 T DE3851265 T DE 3851265T DE 3851265 T DE3851265 T DE 3851265T DE 3851265 D1 DE3851265 D1 DE 3851265D1
Authority
DE
Germany
Prior art keywords
transfer agents
hydrolyzable compounds
analytical use
release electron
electron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3851265T
Other languages
English (en)
Other versions
DE3851265T2 (de
Inventor
Robert Troconis Belly
Patricia Marie Scensny
Annie Liu Wu
Chung-Yuan Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of DE3851265D1 publication Critical patent/DE3851265D1/de
Application granted granted Critical
Publication of DE3851265T2 publication Critical patent/DE3851265T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/46—Phenazines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2304/00—Chemical means of detecting microorganisms
    • C12Q2304/20—Redox indicators
    • C12Q2304/26—Quinone; Quinol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE3851265T 1987-06-08 1988-06-07 Hydrolysierbare Verbindungen, die elektronübertragende Mittel freigeben und ihre analytische Verwendung. Expired - Fee Related DE3851265T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,667 US4952495A (en) 1987-06-08 1987-06-08 Hydrolyzable compounds which release electron transfer agents and analytical use of same

Publications (2)

Publication Number Publication Date
DE3851265D1 true DE3851265D1 (de) 1994-10-06
DE3851265T2 DE3851265T2 (de) 1995-04-13

Family

ID=22024450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3851265T Expired - Fee Related DE3851265T2 (de) 1987-06-08 1988-06-07 Hydrolysierbare Verbindungen, die elektronübertragende Mittel freigeben und ihre analytische Verwendung.

Country Status (4)

Country Link
US (1) US4952495A (de)
EP (1) EP0295034B1 (de)
JP (1) JPS6456669A (de)
DE (1) DE3851265T2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444161A (en) * 1989-08-16 1995-08-22 Microgenics Corporation Substrates for β-galactosidase
DE3940010A1 (de) * 1989-12-02 1991-06-06 Boehringer Mannheim Gmbh Verwendung eines schwer loeslichen salzes einer heteropolysaeure zur bestimmung eines analyts, entsprechendes bestimmungsverfahren sowie hierfuer geeignetes mittel
US5486582A (en) * 1991-07-03 1996-01-23 Shin-Etsu Chemical Co., Ltd. Polymer scale preventive process using a coating of chitosan salt and phenothiazine
DE4217474A1 (de) * 1992-05-27 1993-12-02 Boehringer Mannheim Gmbh Verfahren und Mittel zur Bestimmung eines Analyts
JPH06250353A (ja) * 1993-02-26 1994-09-09 Konica Corp ハロゲン化銀カラー感光材料および撮影ユニット包装体
US5674900A (en) * 1995-06-06 1997-10-07 Shaman Pharmaceuticals, Inc. Terpenoid-type quinones for treatment of diabetes
DE19651886A1 (de) * 1996-12-13 1998-06-18 Merck Patent Gmbh Mittel und Verfahren zur Bestimmung von hydrolytischen Enzymen
WO2002040034A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd. Complexes of phosphate derivatives
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
MXPA04000654A (es) * 2001-07-27 2004-03-19 Vital Health Sciences Pty Ltd Terapia dermica usando derivados de fosfato de agente de transferencia de electrones.
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
NZ565049A (en) * 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
BRPI0621081A2 (pt) * 2005-12-23 2011-11-29 Vital Health Sciences Pty Ltd método de modulação de uma ou mais citocinas imuno-reguladoras, uso de um ou mais derivados de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos, método de inibição de uma resposta inflamatória e/ou de estimulação de uma resposta anti-inflamatória, método de tratamento e/ou de profilaxia de distúbios imunológicos, distúrbios inflamatórios e/ou distúrbios proliferativos celulares, agente imuno-modulador, agente anti-inflamatório ou agente anti-cáncer e um ou mais derivado de fosfato de um ou mais hidróxi cromanos ou complexos dos mesmos
EP2531047A4 (de) 2010-02-05 2014-03-19 Phosphagenics Ltd Träger mit einem nichtneutralisierten tocopherylphosphat
EP2552486B1 (de) 2010-03-30 2020-08-12 Phosphagenics Limited Pflaster für transdermale verabreichung
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
AU2017381395A1 (en) 2016-12-21 2019-06-20 Phosphagenics Limited Process

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA670378A (en) * 1963-09-10 Folkers Karl Phosphates of 2,3-dimethoxy-5-methyl hydroquinones
US2372655A (en) * 1939-11-30 1945-04-03 Winthrop Chem Co Inc Derivatives of the 2-alkyl-1,4-naphthoquinone
US3201385A (en) * 1963-02-11 1965-08-17 Polaroid Corp Synthesis of arbutin
DE1543334A1 (de) * 1966-03-04 1969-08-07 Battelle Development Corp Fungicid wirksame,substituierte Brenzcatechinester der Phosphor- und Thophosphorsaeure und Verfahren zu ihrer Herstellung
CA1095819A (en) * 1977-01-14 1981-02-17 Eastman Kodak Company Element for analysis of liquids
US4160645A (en) * 1977-07-14 1979-07-10 Syva Company Catalyst mediated competitive protein binding assay
DE2831580C2 (de) * 1978-07-18 1980-09-18 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagens zur Bestimmung von Glycerin
DE2834706A1 (de) * 1978-08-08 1980-02-14 Boehringer Mannheim Gmbh Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat-pyruvat-transaminase
US4446231A (en) * 1979-10-03 1984-05-01 Self Colin H Immunoassay using an amplified cyclic detection system
GB2073734B (en) * 1980-04-10 1984-06-06 Kodak Ltd Blocked electron transfer agents
EP0060123B1 (de) * 1981-03-07 1986-10-29 Colin Henry Self Test und seine Verwendung
JPS59192099A (ja) * 1983-04-12 1984-10-31 Ajinomoto Co Inc 微生物菌数の測定法
JPS59204167A (ja) * 1983-05-02 1984-11-19 Takeda Chem Ind Ltd ヒドロキノン誘導体およびその製法
JPH0832621B2 (ja) * 1985-02-28 1996-03-29 株式会社資生堂 皮膚外用剤
DE3412939A1 (de) * 1984-04-06 1985-10-17 Behringwerke Ag, 3550 Marburg Substrate fuer hydrolasen, verfahren zu ihrer herstellung und ihre verwendung
GB8432069D0 (en) * 1984-12-19 1985-01-30 Iq Bio Ltd Apparatus for immunoassay
US4746607A (en) * 1985-02-07 1988-05-24 Eastman Kodak Company Use of substituted quinone electron transfer agents in analytical determinations
JPS61221107A (ja) * 1985-03-28 1986-10-01 Shiseido Co Ltd 皮膚外用剤

Also Published As

Publication number Publication date
US4952495A (en) 1990-08-28
JPS6456669A (en) 1989-03-03
EP0295034A2 (de) 1988-12-14
EP0295034B1 (de) 1994-08-31
DE3851265T2 (de) 1995-04-13
EP0295034A3 (de) 1991-02-27

Similar Documents

Publication Publication Date Title
DE3851265T2 (de) Hydrolysierbare Verbindungen, die elektronübertragende Mittel freigeben und ihre analytische Verwendung.
DE3884140T2 (de) Azazyklische Verbindungen, ihre Herstellung und ihre Verwendung.
NL300045I2 (nl) Fluorcytidine-derivaten, de bereiding daarvan en geneesmiddelen die deze derivaten bevatten.
DE3781569T2 (de) Mittel zur oralen verwendung.
NO891373L (no) Baerbart spektrofotometer.
DE68914495T2 (de) Antihypercholesterolemisches Mittel.
DE69003548T2 (de) Transparente schweisshemmende Mittel und Herstellungsverfahren.
FI914394A0 (fi) Anordning foer utloesning av chockvaogor.
DE3779836D1 (de) Iodopropargylcarbamat-derivate, herstellungsverfahren und fungizide mittel, die diese verbindungen enthalten.
FI873944A (fi) Foerfarande foer framstaellning av vaermebestaendiga, pao epoxihartsbasis strukturerade skikt.
DE3884742D1 (de) Fluoreszierende Verbindungen und deren Verwendung.
DE69009122D1 (de) Aufwärts und abwärts Zerhacker.
DE3781847D1 (de) Pyrimidinderivate, ihre herstellung und medikamente die diese derivate enthalten.
ATE89826T1 (de) Antibakterielle verbindungen, ihre herstellung und verwendung.
DE3779842T2 (de) Antiallergisches mittel.
DE3868474D1 (de) Insektizides mittel.
ATA95689A (de) Maeh- bzw. haeckselmaschine
FI915395A0 (fi) Anvaendningen av melatoninderivat foer att foerhindra befruktning.
FI872608A0 (fi) Anvaendning av kromhaltig legering.
DE59008784D1 (de) Monochromator.
DE3767812D1 (de) Nietpresse.
DE69104291D1 (de) Spergulinähnliche Verbindungen und ihre Verwendung.
DE68907244D1 (de) Anti-arteriosklerotisches mittel.
FI893484A0 (fi) Anordning vid en behaollare foer transport av massgods.
FI875637A0 (fi) Anordning foer att ansluta redskap till fraemre aendan av agrikulturellt anvaendbara motorfordon, speciellt lantbrukstraktorer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC., ROCH

8328 Change in the person/name/address of the agent

Free format text: STREHL, SCHUEBEL-HOPF, GROENING & PARTNER, 80538 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee